Simultaneous very late angiographic stent thrombosis of 2 drug-eluting stents: a case report

American Journal of Emergency Medicine

Volumn 27, Issue 1, 2009, Pages 131.e5-131.e8

  Quercia, Joseph H ^a   Kane, Bryan G ^a   Kane, Kathleen E ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; HEART CATHETERIZATION; HEART RATE; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; OXYGEN SATURATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THORAX PAIN; THROMBOSIS; VITAL SIGN;

EID: 56749159944     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.04.027     Document Type: Article

References (11)

1. Kawaguchi R., Angiolillo D.J., Futamatsu H., Suzuki N., Bass T.A., and Costa M.A. Stent thrombosis in the era of drug eluting stents. Minerva Cardioangiol 55 2 (2007) 199-211
2. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabaté M., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
3. Luscher T., Steffel J., Eberli F., Joner M., Nakazawa G., Tanner F.C., et al. Drug-eluting stent and coronary thrombosis. Circulation 115 (2007) 1051-1058
4. Harper R. Drug-eluting coronary stents-a note of caution. MJA 186 (2007) 253-255
5. Clark D., Wong M., Chan R., Oliver L.E., and Ajani A.E. Very late drug-eluting stent thrombosis. Cardiovasc Revasc Med 8 (2007) 72-75
6. Ong A., McFadden E., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
7. McFadden E., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al. Late thrombosis on drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
8. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
9. Eisenstein E., Anstrom K., Kong D., Shaw L.K., Tuttle R.H., Mark D.B., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
10. Grines C.L., Bonow R.O., Casey Jr. D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 (2007) 734-739
11. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202